CEO Nils Brünner (Scandion Oncology) and CEO Per Norlén (Alligator Bioscience) comments on the preclinical collaboration in the BioStock Studio.
>https://www.biostock.se/2020/06/biostock-studio-scandion-oncology-och-alligator-bioscience-kommenterar-prekliniskt-samarbete/